Hidradenitis Suppurativa and Type 2 Diabetes: A Case Report

    Published on:December 2021
    Journal of Young Pharmacists, 2021; 13(4):434-435
    Case Report | doi:10.5530/jyp.2021.13.103
    Authors:

    Andhuvan Gandhi1,*, Naveen Gunasekaran2, Kaviya Ganesamoorthy2, Megha Mary Tomson1, Reshma Raju1, Shabana Abdulkhader1

    1Department of Pharmacy Practice, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu, INDIA.

    2Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore, Tamil Nadu, INDIA.

    Abstract:

    Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by lesions and abscesses associated with the apocrine gland. Suggested pathogenesis for the disease development include genetic mutations, impaired immuneregulation, and lifestyle factors.Strong associations with obesity and significant improvement in HS severity with weight loss have been reported in various literatures. A sequence of inflammatory events begins with the disruption of follicular epithelium leading to a huge immune response. Patients also become vulnerable to secondary bacterial infections. Diabetes due to its close relation with obesity, and anemia are commonly observed co-morbidities accompanying HS. Available treatment options include antibiotics, pain-relievers and biological therapy. This case report focusses on a 28 year old male admitted with typical symptoms of HS. The physical presentation and thorough blood work led to the diagnosisof HS and Type 2 diabetes mellitus (T2DM). Wound care and treatment with antibiotic combination, adalimumab and metformin showed to be effective.

    Key words: Adjuvant therapy, Anemia, Hidradenitis suppurativa, Obesity, T2DM, Wound care.

    Article Download

     

    Navigation